Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 81 record(s)

Req # A-2020-000850

Adverse Drug Reactions (ADRs). Report numbers: E2B_03195128, E2B_03196066, E2B_03198278, E2B_03198292.

Organization: Health Canada

51 page(s)
January 2024

Req # A-2021-000440

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-100203-189, Status of the use of Remotely Piloted Aircraft Systems (drones) for pesticide application in Canada.

Organization: Health Canada

9 page(s)
January 2024

Req # A-2021-001787

Adverse Drug Reaction (ADR) for AGALSIDASE BETA. Report number: E2B_04595165.

Organization: Health Canada

15 page(s)
January 2024

Req # A-2022-000123

Adverse Drug Reaction (ADR) for ALFUZOSIN HYDROCHLORIDE. Report number: E2B_05007203.

Organization: Health Canada

12 page(s)
January 2024

Req # A-2023-000126

Adverse Drug Reactions (ADRs). Report numbers: E2B_00675714, E2B_02977829, E2B_03128456.

Organization: Health Canada

82 page(s)
January 2024

Req # A-2023-001017

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-107682-242, Deputy Ministerial Meeting with Helium Developers Association of Canada.

Organization: Health Canada

4 page(s)
January 2024

Req # A-2023-001167

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-109485-722, Deputy Ministerial Meeting with the President and Chief Executive Officer of The Ottawa Hospital.

Organization: Health Canada

6 page(s)
January 2024

Req # A-2023-000483

A list of every drug approved under Health Canada's Special Access Program (SAP) between January 1, 2018 and July 6, 2023.

Organization: Health Canada

5266 page(s)
January 2024

Req # A-2023-000968

Information on the intended use of a device listed on Medical Device Active License Listing (MDALL). Requesting it for the following: Licence No.: 95942, Type: System, Device class: 2, Device first issue date 2015-10-15, Licence name: VIASURE, Device first issue date: 2015-10-15, Device name: OW100 - APPLICATORS, Identifier first issue date: 2015-10-15, Device identifiers: OE035, OE050, OP155 and Device first issue date: 2021-08-05, Device name - VIASURE, Identifier first issue date: 2021-08-05, Device identifiers: 1000017.

Organization: Health Canada

4 page(s)
January 2024

Req # A-2022-000907

Records generated from Jan 1, 2008 and Jan 1, 2022, regarding the amount of deaths per year in Canada due to lung cancer. Statistics and data, along with any information explaining the patient’s history. Statistics on if radon was listed as a cause for the cancer.

Organization: Health Canada

650 page(s)
January 2023
Date modified: